John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATW
376
DELISTED
Atwood Oceanics
ATW
| $11.4M | 0.05% |
+1,116,376
| New | +$17.1M |
|
377
PUT
Biogen
BIIB
$32B
| $11.3M | 0.05% |
+37,000
| New | +$10.6M |
|
378
Commault Systems
CVLT
$5.55B
| $11.3M | 0.05% |
287,445
-48,709
| -14% | -$1.9M |
|
379
Tanger
SKT
$4.39B
| $11.3M | 0.05% |
+345,509
| New | +$11.7M |
|
380
PUT
Bristol-Myers Squibb
BMY
$137B
| $11.3M | 0.05% |
+164,000
| New | +$10.8M |
|
381
Hain Celestial
HAIN
$71.6M
| $11.3M | 0.05% |
278,722
+232,549
| +504% | +$10.5M |
|
382
CGI
GIB
$15.5B
| $11.2M | 0.05% |
280,315
+51,512
| +23% | +$2.05M |
|
383
PUT
JPMorgan Chase
JPM
$935B
| $11.2M | 0.05% |
170,000
+134,000
| +372% | +$8.73M |
|
384
ScottsMiracle-Gro
SMG
$3.55B
| $11.2M | 0.05% |
172,910
-29,566
| -15% | -$1.96M |
|
385
Brixmor Property Group
BRX
$8.99B
| $11.1M | 0.05% |
430,175
+371,691
| +636% | +$9.32M |
|
386
RPM International
RPM
$13.9B
| $11M | 0.05% |
250,673
+231,588
| +1,213% | +$10.4M |
|
|
CST
387
DELISTED
CST Brands, Inc.
CST
| $11M | 0.05% |
280,873
+212,225
| +309% | +$7.77M |
|
388
D.R. Horton
DHI
$41.5B
| $10.9M | 0.05% |
+341,376
| New | +$10.7M |
|
|
PACW
389
DELISTED
PacWest Bancorp
PACW
| $10.9M | 0.05% |
253,563
+91,383
| +56% | +$4.11M |
|
390
PUT
Citigroup
C
$221B
| $10.9M | 0.05% |
211,000
+144,000
| +215% | +$7.64M |
|
391
International Paper
IP
$22B
| $10.9M | 0.05% |
305,745
-126,502
| -29% | -$4.87M |
|
392
Insulet
PODD
$10.3B
| $10.9M | 0.05% |
+288,193
| New | +$9.7M |
|
|
PPS
393
DELISTED
Post Properties
PPS
| $10.9M | 0.05% |
183,887
+143,221
| +352% | +$8.48M |
|
394
Lennox International
LII
$13.9B
| $10.9M | 0.05% |
+86,890
| New | +$11.2M |
|
395
CALL
Wells Fargo
WFC
$254B
| $10.8M | 0.05% |
199,000
+61,200
| +44% | +$3.32M |
|
|
WMGI
396
DELISTED
Wright Medical Group Inc
WMGI
| $10.8M | 0.05% |
445,084
-66,530
| -13% | -$1.44M |
|
|
TVPT
397
DELISTED
Travelport Worldwide Limited
TVPT
| $10.7M | 0.05% |
+832,672
| New | +$11.4M |
|
|
SEE
398
DELISTED
Sealed Air
SEE
| $10.7M | 0.05% |
240,589
+144,994
| +152% | +$6.72M |
|
399
Crane NXT
CXT
$2.89B
| $10.7M | 0.05% |
644,979
+261,597
| +68% | +$4.53M |
|
|
BRFS
400
DELISTED
BRF SA
BRFS
| $10.7M | 0.05% |
+773,944
| New | +$12.1M |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.